Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bradac

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Virology|April 30, 1986
Polypeptides of Mason-Pfizer monkey virus. III. Translational order of proteins on the gag and env gene specified precursor polypeptidesJ A Bradac, E Hunter
AIDS (London, England)|January 31, 2002
The HIV vaccine pipeline, from preclinical to phase IIIA M Schultz, J A Bradac
Journal of Virology|December 1, 1982
Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesisS Chatterjee, J A Bradac, E Hunter
Virology|April 30, 1985
Molecular cloning of the Mason-Pfizer monkey virus genome: characterization and cloning of subgenomic fragmentsC S Barker, J W Wills, J A Bradac, et al.
The Journal of Infectious Diseases|May 1, 1997
Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working GroupM P D'Souza, D Livnat, J A Bradac, et al.
Molecular and Cellular Biology|January 1, 1989
Isolation and characterization of related cDNA clones encoding skeletal muscle beta-tropomyosin and a low-molecular-weight nonmuscle tropomyosin isoformJ A Bradac, C E Gruber, S Forry-Schaudies, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary diseaseM T Reymann, J A Bradac, C G Cobbs, et al.
AIDS (London, England)|August 1, 1995
Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodiesM P D'Souza, G Milman, J A Bradac, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1990
Vectors and genes for improvement of animal strainsS H Hughes, C J Petropoulos, M J Federspiel, et al.
AIDS Research and Human Retroviruses|November 1, 1994
Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and CharacterizationF Gao, L Yue, S Craig, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Virology|April 30, 1986
Polypeptides of Mason-Pfizer monkey virus. III. Translational order of proteins on the gag and env gene specified precursor polypeptidesJ A Bradac, E Hunter
AIDS (London, England)|January 31, 2002
The HIV vaccine pipeline, from preclinical to phase IIIA M Schultz, J A Bradac
Journal of Virology|December 1, 1982
Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesisS Chatterjee, J A Bradac, E Hunter
Virology|April 30, 1985
Molecular cloning of the Mason-Pfizer monkey virus genome: characterization and cloning of subgenomic fragmentsC S Barker, J W Wills, J A Bradac, et al.
The Journal of Infectious Diseases|May 1, 1997
Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working GroupM P D'Souza, D Livnat, J A Bradac, et al.
Molecular and Cellular Biology|January 1, 1989
Isolation and characterization of related cDNA clones encoding skeletal muscle beta-tropomyosin and a low-molecular-weight nonmuscle tropomyosin isoformJ A Bradac, C E Gruber, S Forry-Schaudies, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1979
Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary diseaseM T Reymann, J A Bradac, C G Cobbs, et al.
AIDS (London, England)|August 1, 1995
Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodiesM P D'Souza, G Milman, J A Bradac, et al.
Journal of Reproduction and Fertility. Supplement|January 1, 1990
Vectors and genes for improvement of animal strainsS H Hughes, C J Petropoulos, M J Federspiel, et al.
AIDS Research and Human Retroviruses|November 1, 1994
Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and CharacterizationF Gao, L Yue, S Craig, et al.
Pageof 2